Indication
Placebo Ethanol
1 clinical trial
2 products
1 drug
Clinical trial
Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in HumansStatus: Active (not recruiting), Estimated PCD: 2022-06-30
Product
Active EthanolProduct
IomazenilDrug
Varlilumab